奇精機械(603677.SH):東證睿禾完成清算註銷
格隆匯3月16日丨奇精機械(603677.SH)公佈,公司於2020年10月26日召開第三屆董事會第十三次會議,審議通過了《關於將諸暨東證睿禾投資合夥企業(有限合夥)清算並註銷的議案》,同意將東證睿禾投資合夥企業(有限合夥)(以下簡稱“東證睿禾”)清算並註銷。
2021年3月15日,東證睿禾辦理完成了銀行賬户銷户手續。賬户註銷前,東證睿禾將賬户留存資金及期間利息合計24.80萬元進行分配。同日公司收到分配款項20.67萬元。截至本報吿披露日,東證睿禾已完成全部清算註銷事宜。截至2021年3月15日,公司已收回全部本金及對應收益共計2020.67萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.